comparemela.com

Latest Breaking News On - Clinical research excluding trials - Page 1 : comparemela.com

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of

Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers

United statesSan diegoSanjoy kumar dasChristian marsolaisJulie schneidermanPhilippe dubucMichel demeuleAmerican association for cancer researchCommunications corporate affairsTheratechnologies incClinical research excluding trialsCompany phaseAmerican associationCancer researchAnnual meetingSenior vice president

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision.

United statesLee cranmerGopa iyerClinical research excluding trialsMemorial sloan kettering cancer centerFred hutch cancer centerAadi bioscience incPrnewswire aadi bioscience incPoster sessionMolecularly targeted agentsMemorial sloan kettering cancerSession display dateBoard numberDiscussion session dateClinical research excludingPoster discussion session

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGopa iyerMarcy grahamLee cranmerAadi bioscienceAadi bioscience incPrnewswire aadi bioscience incMemorial sloan kettering cancer centerClinical research excluding trialsFred hutch cancer centerPoster sessionMolecularly targeted agentsMemorial sloan kettering cancerSession display dateBoard numberDiscussion session date

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision.

United statesLee cranmerAadi biosciencesGopa iyerPrnewswire aadi bioscience incMemorial sloan kettering cancer centerAadi bioscience incCompany annual report on formFred hutch cancer centerClinical research excluding trialsInvestigator initiatedPoster sessionMolecularly targeted agentsMemorial sloan kettering cancerSession display dateBoard number

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGopa iyerAadi bioscienceLee cranmerAadi biosciencesMarcy grahamClinical research excluding trialsAadi bioscience incPrnewswire aadi bioscience incMemorial sloan kettering cancer centerCompany annual report on formFred hutch cancer centerInvestigator initiatedPoster sessionMolecularly targeted agentsMemorial sloan kettering cancer

vimarsana © 2020. All Rights Reserved.